These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24378885)

  • 21. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
    Adabag AS; Maron BJ; Appelbaum E; Harrigan CJ; Buros JL; Gibson CM; Lesser JR; Hanna CA; Udelson JE; Manning WJ; Maron MS
    J Am Coll Cardiol; 2008 Apr; 51(14):1369-74. PubMed ID: 18387438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy with dominant hypertrophy in the right anterobasal region of the ventricular septum: a case report.
    Matsubara T; Yamazoe M; Kimura M; Hori T; Ozaki K; Hatada K; Aizawa Y
    J Cardiol; 2000 Jul; 36(1):45-8. PubMed ID: 10929265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging.
    Mangold S; Kramer U; Franzen E; Erz G; Bretschneider C; Seeger A; Claussen CD; Niess AM; Burgstahler C
    Rofo; 2013 Dec; 185(12):1167-74. PubMed ID: 23897528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right bundle branch block and ventricular septal fibrosis in patients with hypertrophic cardiomyopathy.
    Harimoto K; Kawasaki T; Honda S; Miki S; Kamitani T
    J Electrocardiol; 2014; 47(5):636-41. PubMed ID: 25042853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
    Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K; Hirano M; Ookubo H; Sasaki K; Katsuyama H; Amino M; Abe Y; Yamashina A
    Magn Reson Imaging; 2004 Feb; 22(2):155-61. PubMed ID: 15010107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups).
    Barbosa CA; Castro CC; Avila LF; Parga Filho JR; Hattem DM; Fernandez EA
    Arq Bras Cardiol; 2009 Oct; 93(4):426-33, 418-25. PubMed ID: 19936464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biventriculographic and clinicopathologic evaluation of apical hypertrophy: with reference to asymmetrical septal hypertrophy with hypertension].
    Genda A; Taga K; Nakayama A; Nunoda S; Horita Y; Sugihara N; Takeda R
    J Cardiogr; 1985 Jun; 15(2):327-38. PubMed ID: 4093618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of regional hypertrophy in hypertrophic cardiomyopathy with ECG triggered nuclear magnetic resonance tomography--comparison with hypertensive patients and persons with healthy hearts].
    Schneider R; Köhler D; Berghöfer G; Paeprer H; Felix R; Thormann I; Schörner W; Schmutzler H
    Z Kardiol; 1985 Mar; 74(3):144-51. PubMed ID: 3158127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and hypertrophic segments distribution of patients with hypertrophic cardiomyopathy].
    YAN CW; ZHAO SH; LI H; JIANG SL; LU MJ; ZHANG Y; WEI YQ; LING J; FANG W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):781-5. PubMed ID: 21092643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
    Chaowu Y; Shihua Z; Jian L; Li L; Wei F
    Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
    Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.